Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Janux Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19
Revenues8.653.43.626.20.03.0
            Revenue growth136.8%103.7%  -100.0% 
Cost of goods sold0.075.70.036.60.06.0
Gross profit8.6-22.33.6-10.30.0-3.0
            Gross margin100.0%-41.7%100.0%-39.4% -100.0%
Research and development53.4 26.2 3.0 
General and administrative22.322.310.310.31.80.8
EBIT-67.1-67.1-32.9-32.9-4.8-3.8
            EBIT margin-779.0%-125.5%-905.4%-125.5% -125.7%
Pre-tax income-63.1-63.1-32.7-32.7-6.80.0
Income taxes0.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0% 
Net income-63.1-63.1-32.7-32.7-6.80.0
            Net margin-732.2%-118.0%-898.3%-124.5% 0.0%
 
Diluted EPS($1.52)($1.52)($1.39)($1.39)($7.41)$0.00
Shares outstanding (diluted)41.541.523.523.50.9669.4
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy